Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

TARGETMOL CHEMICALS INC BIMIRALISIB 10MG
SDP

Supplier:  TARGETMOL CHEMICALS INC T2265

Encompass_Preferred

Also available in 1 mg 2 mg 5 mg 25 mg 50 mg 100 mg 500 mg and bulk. Please contact Fisher for quotes. Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha beta gamma and delta and to a lesser extent mTOR kinase which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth survival and resistance to both chemotherapy and radiotherapy. purity: 99%

Catalog No. 50-257-7185


May include imposed supplier surcharges.
Only null left
Edge
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.